Nrg-hn003: Phase i and expansion cohort study of adjuvant pembrolizumab, cisplatin and radiation therapy in pathologically high-risk head and neck cancer

  • Julie E. Bauman
  • , Jonathan Harris
  • , Ravindra Uppaluri
  • , Min Yao
  • , Robert L. Ferris
  • , Josephine Chen
  • , Richard C. Jordan
  • , Nikhil P. Joshi
  • , Srinivas Jujjuvaparu
  • , Dukagjin M. Blakaj
  • , Christina Henson
  • , Jawad Sheqwara
  • , Loren K. Mell
  • , Neilayan Sen
  • , David A. Clump
  • , Madhur K. Garg
  • , Emrullah Yilmaz
  • , Pedro Torres-Saavedra
  • , Quynh Thu Le

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Nrg-hn003: Phase i and expansion cohort study of adjuvant pembrolizumab, cisplatin and radiation therapy in pathologically high-risk head and neck cancer'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry